Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Battaglia

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Methods in Enzymology|March 4, 2020
Neoantigen prediction from genomic and transcriptomic dataSebastiano Battaglia
Current Opinion in Biotechnology|March 25, 2016
Unmasking targets of antitumor immunity via high-throughput antigen profilingSebastiano Battaglia, Jason B Muhitch
International Journal of Cancer|January 22, 2010
Transcription factor co-repressors in cancer biology: roles and targetingSebastiano Battaglia, Orla Maguire, Moray J Campbell
International Review of Cell and Molecular Biology|January 13, 2019
In Silico Methods for Studying T Cell BiologyKatherine Grzesik, Kevin Eng, Fabien Crauste, et al.
Hematology/Oncology Clinics of North America|November 5, 2018
Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian CancerThinle Chodon, Amit A Lugade, Sebastiano Battaglia, et al.
Immunology|May 18, 2018
Nature of tumour rejection antigens in ovarian cancerMuzamil Y Want, Amit A Lugade, Sebastiano Battaglia, et al.
International Journal of Molecular Sciences|August 27, 2021
Inhibition of WHSC1 Allows for Reprogramming of the Immune Compartment in Prostate CancerMuzamil Y Want, Ellen Karasik, Bryan Gillard, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 3, 2015
Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cellsCraig L Doig, Sebastiano Battaglia, Farhat L Khanim, et al.
Nutrients|November 6, 2019
ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite SignallingSamantha A Hutchinson, Priscilia Lianto, Hanne Roberg-Larsen, et al.
International Journal of Molecular Sciences|January 21, 2023
Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung CancerLiana Bruggemann, Zackary Falls, William Mangione, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Methods in Enzymology|March 4, 2020
Neoantigen prediction from genomic and transcriptomic dataSebastiano Battaglia
Current Opinion in Biotechnology|March 25, 2016
Unmasking targets of antitumor immunity via high-throughput antigen profilingSebastiano Battaglia, Jason B Muhitch
International Journal of Cancer|January 22, 2010
Transcription factor co-repressors in cancer biology: roles and targetingSebastiano Battaglia, Orla Maguire, Moray J Campbell
International Review of Cell and Molecular Biology|January 13, 2019
In Silico Methods for Studying T Cell BiologyKatherine Grzesik, Kevin Eng, Fabien Crauste, et al.
Hematology/Oncology Clinics of North America|November 5, 2018
Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian CancerThinle Chodon, Amit A Lugade, Sebastiano Battaglia, et al.
Immunology|May 18, 2018
Nature of tumour rejection antigens in ovarian cancerMuzamil Y Want, Amit A Lugade, Sebastiano Battaglia, et al.
International Journal of Molecular Sciences|August 27, 2021
Inhibition of WHSC1 Allows for Reprogramming of the Immune Compartment in Prostate CancerMuzamil Y Want, Ellen Karasik, Bryan Gillard, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 3, 2015
Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cellsCraig L Doig, Sebastiano Battaglia, Farhat L Khanim, et al.
Nutrients|November 6, 2019
ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite SignallingSamantha A Hutchinson, Priscilia Lianto, Hanne Roberg-Larsen, et al.
International Journal of Molecular Sciences|January 21, 2023
Multiscale Analysis and Validation of Effective Drug Combinations Targeting Driver KRAS Mutations in Non-Small Cell Lung CancerLiana Bruggemann, Zackary Falls, William Mangione, et al.
Pageof 5